TrialBreast (Edinburgh, Scotland)2020

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer.

Xiuwen Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.